Dr. Seungwon Kim is chief of the Division of Head and Neck Surgery and an associate professor in the Department of Otolaryngology at the University of Pittsburgh School of Medicine. Dr. Kim has received his board certification in Otolaryngology–Head and Neck Surgery. Dr. Kim received his medical degree from the State University of New York at Syracuse. He completed a residency in the Department of Otolaryngology–Head and Neck Surgery at the State University of New York at Syracuse. Afterwards, he completed a Research Fellowship in Head and Neck Surgical Oncology and a clinical fellowship in the Department of Head and Neck Surgery at U.T.M.D. Anderson Cancer Center in Houston, Texas. Dr. Kim is rated as an Elite provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Gastrostomy.

Matthew E. Spector, MD, FACS, completed his medical school training at Stritch School of Medicine, Loyola University in Chicago. He then went on to the University of Michigan where he completed his residency in Otolaryngology – Head and Neck Surgery and fellowship in Head and Neck Surgical Oncology and Microvascular Reconstruction. He was on faculty at the University of Michigan for 10 years where he served as the Director of the Head and Neck Oncology Program and Associate Director of the Head and Neck Surgical Oncology and Microvascular Reconstruction Fellowship. Dr. Spector is rated as an Elite provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Glossectomy.

Steven B. Chinn, MD, specializes in otolaryngology and is board-certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. He is affiliated with UPMC Mercy, UPMC Shadyside, UPMC Magee-Womens Hospital, UPMC Presbyterian and UPMC East. Dr. Chinn completed his fellowship at the University of Texas, residency at the University of Michigan Medical Center and medical degree at the University of Southern California Keck School of Medicine. Dr. Chinn is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy.

Jose Zevallos is an Otolaryngologist in Pittsburgh, Pennsylvania. Dr. Zevallos is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Laryngectomy, and Thyroidectomy.

Kevin J. Contrera, MD, MPH, received his medical degree from Johns Hopkins University School of Medicine. He completed residency in otolaryngology-head and neck surgery at Cleveland Clinic before pursuing fellowships in advanced head & neck surgical oncology and microvascular reconstructive surgery at MD Anderson Cancer Center. Dr. Contrera is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Velopharyngeal Insufficiency, Sinus Cancer, Glossectomy, and Laryngectomy.

Shaum Sridharan, MD, graduated from the University of Texas where he also received his medical degree. He completed his residency in otolaryngology at New York University before pursuing dual fellowships in head and neck oncology at the University of South Carolina and Laryngology at the University of Pittsburgh. Dr. Sridharan is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Laryngeal Cancer, Glossectomy, and Mastoidectomy.

Dr. Jonas Johnson is a professor of otolaryngology and radiation oncology at the University of Pittsburgh School of Medicine Department of Otolaryngology and a professor of oral and maxillofacial surgery at the University of Pittsburgh School of Dental Medicine. In addition, he has been named as a top doctor in America by Castle Connolly Medical Ltd. Dr. Johnson has received many awards for his teaching and medical accomplishments and is a past president of both the American Academy of Otolaryngology–Head and Neck Surgery and the American Head and Neck Society. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Swallowing Difficulty, Throat Cancer, Laryngectomy, and Glossectomy.

Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.

Apostolos Christopoulos is an Otolaryngologist in Pittsburgh, Pennsylvania. Dr. Christopoulos is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngectomy, and Tissue Biopsy.

Christopher Wilke, MD, specializes in radiation oncology and is board-certified in radiation oncology by the American Board of Radiology. He practices at Mary Hillman Jennings Radiation Oncology Center and is affiliated with UPMC St Margaret, UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Passavant, UPMC East, UPMC Presbyterian, UPMC Shadyside, and UPMC Mercy. Dr. Wilke completed his fellowship at University of Texas MD Anderson Cancer Center and residency and medical education at University of Minnesota School of Medicine. Dr. Wilke is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Optic Glioma, Throat Cancer, Laryngeal Cancer, and Olfactory Neuroblastoma.

Yvonne Mowery, MD, PhD, specializes in radiation oncology and is board-certified by the American Board of Radiology. She practices at Mary Hillman Jennings Radiation Oncology Center and is affiliated with UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Mercy, UPMC Shadyside, and UPMC Presbyterian. Dr. Mowery completed her residency at Duke University Medical Center and medical education at Duke University School of Medicine. Dr. Mowery is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Throat Cancer, Laryngeal Cancer, Adult Soft Tissue Sarcoma, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Heath D. Skinner, MD, PhD, is chair and medical director of the Department of Radiation Oncology and professor at UPMC Hillman Cancer Center, specializing in the study and treatment of head and neck and lung cancer. Dr. Skinner's research is designed to generate insights that led to the rational design of clinical trials using agents that are currently under investigation to minimize the time from bench to bedside. Dr. Skinner is board-certified in radiation oncology. He completed a combined MD/PhD program at West Virginia University. Upon completion of medical school, he began a combined internship and residency in radiation oncology at the University of Texas MD Anderson Cancer Center (MDACC). Over the course of his career, Dr. Skinner has received eight peer-reviewed grants, including a two current R01s funding his research. He has published over 85 peer-reviewed articles , has written 6 book chapters and 9 invited reviews and presented over 50 abstracts at national meetings. Dr. Skinner has also been invited to present his work at multiple domestic and international symposia. In addition to his research, Dr. Skinner is dedicated to providing excellent and compassionate patient care. This dedication is borne out in patient experience measures, with his scores being almost uniformly in the 99th percentile for all categories asked. Moreover, his patients have rated him in the top 1 percent nationally on Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) measures related to their experience with him in his clinic. Dr. Skinner is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Esophageal Cancer, Anaplastic Thyroid Cancer, Lung Cancer, and Gastrostomy.

Zahra Rahman Kelly, DO, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Kelly is trained in the management of all cancers and blood disorders with a focus in genitourinary and head and neck malignancies.  Dr. Kelly is board-certified in nternal medicine and medical oncology and hematology. She received her medical degree from Philadelphia College of Osteopathic Medicine. Dr. Kelly completed both a residency in internal medicine and a fellowship in hematology/oncology at UPMC. She served as chief fellow during her final year of hematology/oncology fellowship. Her research interests include early phase clinical trial design and cancer immunotherapy combination trials. She has published papers in peer reviewed journals and is an active member of the UPMC Hillman protocol review committee where she reviews therapeutic oncology trials. She also collaborates with surgical oncologists and radiation oncologists to provide multidisciplinary care to her patients. Dr. Kelly is a member of the European Society of Medical Oncology, American Society of Medical Oncology, American Medical Association, and American Society of Hematology. Dr. Kelly is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Febrile Neutropenia, Chronic Familial Neutropenia, and Gamma Knife Radiosurgery.

Philip Pollice, MD, specializes in otolaryngology and is certified in plastic surgery within the head and neck by the American Board of Otolaryngology. He practices at Metropolitan Ear Nose and Throat Associates-UPMC and is affiliated with UPMC East, UPMC St. Margaret, UPMC Jameson, UPMC Northwest, UPMC Passavant, UPMC Mercy, and UPMC Children's Hospital of Pittsburgh. He completed his fellowship and residency at Johns Hopkins School of Medicine, and medical degree at the University of Pennsylvania School of Medicine. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Pollice is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Thyroid Nodule, Infant Hearing Loss, Laryngeal Nerve Damage, DFNB1, and Myringotomy.

Warren Swegal is an Otolaryngologist in Pittsburgh, Pennsylvania. Dr. Swegal is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Mikulicz Disease, Laryngectomy, and Septoplasty.

Garren Low is an Otolaryngologist and a Plastic Surgeon in Pittsburgh, Pennsylvania. Dr. Low has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Male Pattern Baldness, Mikulicz Disease, and Gastrostomy.

Chwee Lim is an Otolaryngologist in Pittsburgh, Pennsylvania. Dr. Lim is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Nasopharyngeal Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Thyroid Nodule, Thyroidectomy, and Endoscopy.

Sarah Davies, DDS, MD, specializes in oral and maxillofacial surgery and is board-certified by the American Board of Oral and Maxillofacial Surgery. She practices at Pittsburgh Oral Surgery, PC and is affiliated with UPMC Presbyterian, UPMC Mercy, and UPMC Children's Hospital of Pittsburgh. Dr. Davies received a medical degree from the University of North Carolina at Chapel Hill Adams School of Dentistry and the University of Pittsburgh School of Medicine and completed her residency at the University of Pittsburgh School of Medicine. Dr. Davies is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Periodontitis, Cherubism, Mouth Sores, and Mouth Ulcers.

Felicia Snead, MD, is the medical director of St. Clair Hospital Cancer Center, Radiation Oncology, affiliated with UPMC Hillman Cancer Center and is a clinical associate professor in the Department of Radiation Oncology at the University of Pittsburgh School of Medicine. She treats all radiation oncology cases. Dr. Snead is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Nasopharyngeal Carcinoma, Breast Cancer, Pleuropulmonary Blastoma, and Pancreatic Cancer.

Darlene Gabeau, MD, PhD, specializes in radiation oncology and is board-certified by the American Board of Radiology. She practices at St. Clair Hospital Cancer Center - UPMC Hillman Cancer Center and is affiliated with UPMC Hamot, UPMC Mercy, UPMC Presbyterian, and UPMC Shadyside. Dr. Gabeau received her medical degree from Yale School of Medicine and completed her residency at Harvard Medical School (Radiation Oncology Program). Dr. Gabeau is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Breast Cancer, Metastatic Brain Tumor, Lung Cancer, and Pleuropulmonary Blastoma.